English
Select site language

Nobivac L4 (Leptospira interrogans serogroup Canicola...) – Conditions or restrictions regarding supply and use - QI07AB01

Updated on site: 09-Feb-2018

Medication name: Nobivac L4
ATC: QI07AB01
Substance: Leptospira interrogans serogroup Canicola serovar Portland-vere (strain Ca-12-000) / L. interrogans serogroup Icterohaemorrhagiae serovar Copenhageni (strain Ic-02-001) / L. interrogans serogroup Australis serovar Bratislava (strain As-05-073) / L. kirsch
Manufacturer: Intervet International BV

A. MANUFACTURER OF THE BIOLOGICAL ACTIVE SUBSTANCES AND MANUFACTURER RESPONSIBLE FOR BATCH RELEASE

Name and address of the manufacturer of the biological active substances

Intervet International B.V. Wim de Körverstraat 35 5831 AN Boxmeer

The Netherlands

Name and address of the manufacturer responsible for batch release

Intervet International B.V. Wim de Körverstraat 35 5831 AN Boxmeer

The Netherlands

B.CONDITIONS OR RESTRICTIONS REGARDING SUPPLY AND USE

Veterinary medicinal product subject to prescription.

C.STATEMENT OF THE MRLs

Not applicable.

Comments